Suspected cutaneous anthrax in a laboratory workerߞTexas, 2002

Journal of the American Medical Association

Volumn 287, Issue 18, 2002, Pages 2356-2358

  Mackey, T A ^a   Page, E H ^b   Martinez, K F ^b   Sietz, T A ^b   Bernard, B P ^b   Tepper, A L ^b   Weyant, R S ^c   Rosenstein, N E ^d   Perkins, B A ^d   Popovic, T ^d   Holmes, H T ^e   Shepard, C W ^e,f  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c Office of Health and Safety   (United States)

^d MS D 63   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Anthrax; Bacillus anthracis; From the centers for disease control and prevention; Occupational exposure; Texas

Indexed keywords

CIPROFLOXACIN;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOLOGICAL WARFARE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENVIRONMENTAL SANITATION; HEALTH HAZARD; HUMAN; INFECTION PREVENTION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; SHORT SURVEY; SKIN DISEASE;

EID: 0037042245     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.18.2356     Document Type: Article

References (4)

1. APIC guidelines for infection control practice
2. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee of Immunization Practices
3. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines